A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria (Q40801803)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria |
scientific article |
Statements
1 reference
A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria (English)
1 reference
de Souza JM
1 reference
Sheth UK
1 reference
Wernsdorfer WH
1 reference
Trigg PI
1 reference
Doberstyn EB
1 reference
1 January 1987
1 reference
1 reference